NCT07726472

Brief Summary

The goal of this cross sectional observational study is to compare the accuracy of placement and performance tests to gold standard method of fiberscope assisted insertion of Supraglottic Airway(SGA) Device for optimal SGA placement, in ASA 1-3 adult patients undergoing general anesthesia in University Malaya Medical Center(UMMC). This study aim to answer:

  • Can placement and performance tests, ie; Oropharyngeal leak(OPL) test, accurately assess for optimal SGA placement?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 14, 2025

Completed
21 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 4, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 28, 2025

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

June 22, 2026

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 24, 2026

Completed
Last Updated

July 24, 2026

Status Verified

March 1, 2026

Enrollment Period

21 days

First QC Date

June 22, 2026

Last Update Submit

July 22, 2026

Conditions

Keywords

Supraglottic airway placement testsSupraglottic airway performance testsFiberscope grading for supraglottic airway placementOropharyngeal leak test(OPL test)Supraglottic Airway (SGA)

Outcome Measures

Primary Outcomes (1)

  • Accuracy of Oropharyngeal leak (OPL) test in determining optimal SGA placement

    OPL test is part of the listed performance test done to evaluate ideal SGA placement and function for ventilation of GA patients. It is measured in cmH20. Positive test is indicated when the value is \>25cmH20.

    From enrollment until end of surgery in recovery.

Secondary Outcomes (7)

  • Accuracy of gastric test in evaluating optimal SGA placement.

    from enrollment until end of surgery, in recovery.

  • Accuracy of suprasternal notch test in evaluating optimal SGA placement.

    from enrollment until end of surgery, in recovery.

  • Accuracy of Maximal minute ventilation test in evaluating optimal SGA placement.

    from enrollment until end of surgery, in recovery.

  • Accuracy of subjective assessment(chest rise) in evaluating optimal SGA placement.

    from enrollment until end of surgery, in recovery.

  • Accuracy of subjective assessment(expired tidal volume) in evaluating optimal SGA placement.

    from enrollment until end of surgery, in recovery.

  • +2 more secondary outcomes

Study Arms (1)

patients undergoing general anesthesia with supraglottic airway

Diagnostic Test: fiberoptic view of glottis

Interventions

fiberscope inserted through ventilation opening and place tip at glottis to capture view.

patients undergoing general anesthesia with supraglottic airway

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing general anesthesia with supraglottic ariway(SGA) in University Malaya Medical Center(UMMC)

You may qualify if:

  • American Society of Anesthesiology(ASA) class 1-3.

You may not qualify if:

  • Patients with limited mouth opening.
  • Patients with pharyngeal or laryngeal abnormalities that affect SGA placement.
  • Patients with high risk of aspiration (gastroparesis, inadequate fasting time, hiatal hernia)
  • Patients with reduced lung or chest compliance or increase airway resistance (ARDS, asthma)
  • Patients with lower safe apneoic time (pregnancy, morbid obesity, sepsis, active lung disease)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Malaya Medical Center

Kuala Lumpur, Kuala Lumpur, 59100, Malaysia

Location

Study Officials

  • jeremy Dr tan, MBBS

    University Malaya Medical Center

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 22, 2026

First Posted

July 24, 2026

Study Start

August 14, 2025

Primary Completion

September 4, 2025

Study Completion

November 28, 2025

Last Updated

July 24, 2026

Record last verified: 2026-03

Locations